iRadimed
IRMD
96 hedge funds and large institutions have $231M invested in iRadimed in 2021 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 28 increasing their positions, 23 reducing their positions, and 8 closing their positions.
300% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 8
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
46% more capital invested
Capital invested by funds: $159M → $231M (+$72.3M)
32% more funds holding
Funds holding: 73 → 96 (+23)
22% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 23
2.15% more ownership
Funds ownership: 38.36% → 40.51% (+2.2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Calamos Advisors
Naperville,
Illinois
|
+$2.81M |
| 2 |
HIM
Hillsdale Investment Management
Toronto,
Ontario, Canada
|
+$2.3M |
| 3 |
Russell Investments Group
London,
United Kingdom
|
+$1.72M |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$1.69M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$1.63M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$3.87M |
| 2 |
MIP
Mondrian Investment Partners
London,
United Kingdom
|
-$2.13M |
| 3 |
FP
Foundry Partners
Minneapolis,
Minnesota
|
-$2.09M |
| 4 |
RIM
Ranger Investment Management
Dallas,
Texas
|
-$1.46M |
| 5 |
NTCM
Nine Ten Capital Management
Chicago,
Illinois
|
-$1.25M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TI
101
Trexquant Investment
Stamford,
Connecticut
| – | -$231K | -6,882 | Closed |
|
102
LPL Financial
San Diego,
California
| – | -$203K | -6,050 | Closed |
|
|
JWA
103
JFS Wealth Advisors
Hermitage,
Pennsylvania
| – | -$59K | -1,750 | Closed |
|
|
OSAM
104
O'Shaughnessy Asset Management
Stamford,
Connecticut
| – | -$2K | -52 | Closed |
|
IRMD Hedge Fund Activity: Q4 2021 in Review
96 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in iRadimed (IRMD) for Q4 2021, worth a combined $231M — up 46% from $159M a quarter earlier.
Buyers outnumbered sellers: 32 funds opened new IRMD positions and 8 closed out — a net gain of 24 holders — while 28 added to existing stakes and 23 trimmed.
The largest buyer was Calamos Advisors, opening a new position worth an estimated $2.81M. The largest seller was Vanguard Group, cutting an estimated $3.87M.
- 96 institutional investors held iRadimed (IRMD) as of Q4 2021, up from 73 in Q3 2021.
- Funds reported $231M of iRadimed stock for Q4 2021, up 46% quarter-over-quarter.
- 32 funds opened new iRadimed positions in Q4 2021 and 8 closed out, a net change of +24 holders.
- The largest iRadimed buyer in Q4 2021 was Calamos Advisors, an estimated $2.81M added.
- The largest iRadimed seller in Q4 2021 was Vanguard Group, an estimated $3.87M sold.
Based on aggregated 13F filings for Q4 2021.